Detomidine hydrochloride
CAS: 90038-01-0
Rif. 3D-FD21398
| 1g | Fuori produzione | ||
| 2g | Fuori produzione | ||
| 5g | Fuori produzione | ||
| 250mg | Fuori produzione | ||
| 500mg | Fuori produzione |
Informazioni sul prodotto
Nome:
Detomidine hydrochloride
Sinonimi:
- 5-[(2,3-Dimethylphenyl)methyl]-1H-imidazole hydrochloride4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochlorideDomosedan
- 1H-Imidazole, 4-[(2,3-dimethylphenyl)methyl]-, monohydrochloride
- 1H-Imidazole, 5-[(2,3-dimethylphenyl)methyl]-, hydrochloride (1:1)
- 4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochloride
- 5-(2,3-dimethylbenzyl)-1H-imidazole hydrochloride (1:1)
- Domosedan
- Dormosedan
- Mpv 253Aii
Descrizione:
Detomidine hydrochloride is a sedative that is used to manage pain in animals. It has a clinical relevance in the treatment of convulsions, seizures, and tetanus. Detomidine hydrochloride has been shown to have 2-adrenergic receptor agonist activity and can cause the release of energy substrates from cells. The drug also alters cardiac function by causing an increase in blood pressure, heart rate, and cardiac output. Detomidine hydrochloride has been shown to alter microdialysis probes for physiological effects such as estradiol benzoate concentration and cortisol concentrations. This drug also has locomotor activity effects on rats that can be inhibited with nonsteroidal anti-inflammatory drugs such as ibuprofen.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
222.71 g/mol
Formula:
C12H15ClN2
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
